Suchergebnisse - "IgG"

PubPharm (30)

1

A pivotal decade for bispecific antibodies?

in: mAbs | 2024

von Marlena Surowka | Christian Klein

2

RUBY® – a tetravalent (2+2) bispecific antibody format with excellent functionality and IgG-like stability, pharmacology and developability properties

in: mAbs | 2024

von Barnabas Nyesiga | Mattias Levin | Anna Säll | +6

3

Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats

in: mAbs | 2023

von Andreas V. Madsen | Peter Kristensen | Alexander K. Buell | +1

4

Impact of IgG subclass on monoclonal antibody developability

in: mAbs | 2023

von Paul Cain | Lihua Huang | Yu Tang | +2

5

A machine learning strategy for the identification of key in silico descriptors and prediction models for IgG monoclonal antibody developability properties

in: mAbs | 2023

von Andrew B. Waight | David Prihoda | Rojan Shrestha | +8

6

Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier

in: mAbs | 2023

von Jason Tien | Dmitri Leonoudakis | Ralitsa Petrova | +11

7

The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa

in: mAbs | 2022

von Yuki Yamaguchi | Natsumi Wakaizumi | Mine Irisa | +10

8

Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography–mass spectrometry

in: mAbs | 2021

von Steffen Lippold | Alexander Knaupp | Arnoud H. de Ru | +9

9

The therapeutic potential of sialylated Fc domains of human IgG

in: mAbs | 2021

von Richard J. Pleass

10

Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation

in: mAbs | 2021

von Bingchuan Wei | Xuan Gao | Lance Cadang | +19